Back to companies
BridgeBio Pharma, Inc.
BBIOUSNASDAQPharmaceuticals & HealthcareBridgeBio Pharma, Inc.
Revenue
$502.1mn
YoY +126.3%
Operating income
-$523.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API